Chen X - Search Results

1

Multi-omics characterization and therapeutic liability of ferroptosis in melanoma.

He Y, Dong Y, Chen Y, Zhang G, Zhang H, Lei G, Du Y, Chen X, Ye Y, Liu H. He Y, et al. Among authors: chen x, chen y. Signal Transduct Target Ther. 2022 Aug 10;7(1):268. doi: 10.1038/s41392-022-01067-y. Signal Transduct Target Ther. 2022. PMID: 35945204 Free PMC article. No abstract available.

2

Lysophosphatidic acid mediates the pathogenesis of psoriasis by activating keratinocytes through LPAR5.

Lei L, Yan B, Liu P, Li J, Chen C, Zhu W, Kuang Y, Chen X, Peng C. Lei L, et al. Among authors: chen c, chen x. Signal Transduct Target Ther. 2021 Jan 15;6(1):19. doi: 10.1038/s41392-020-00379-1. Signal Transduct Target Ther. 2021. PMID: 33452232 Free PMC article. No abstract available.

3

Pyroptosis: mechanisms and diseases.

Yu P, Zhang X, Liu N, Tang L, Peng C, Chen X. Yu P, et al. Among authors: chen x. Signal Transduct Target Ther. 2021 Mar 29;6(1):128. doi: 10.1038/s41392-021-00507-5. Signal Transduct Target Ther. 2021. PMID: 33776057 Free PMC article. Review.

4

Research Trends in Immune Checkpoint Blockade for Melanoma: Visualization and Bibliometric Analysis.

Xu Y, Jiang Z, Kuang X, Chen X, Liu H. Xu Y, et al. Among authors: chen x. J Med Internet Res. 2022 Jun 27;24(6):e32728. doi: 10.2196/32728. J Med Internet Res. 2022. PMID: 35759331 Free PMC article.

5

Human umbilical cord mesenchymal stem cells for psoriasis: a phase 1/2a, single-arm study.

Cheng L, Wang S, Peng C, Zou X, Yang C, Mei H, Li C, Su X, Xiao N, Ouyang Q, Zhang M, Wang Q, Luo Y, Shen M, Qin Q, Wang H, Zhu W, Lu G, Lin G, Kuang Y, Chen X. Cheng L, et al. Among authors: chen x. Signal Transduct Target Ther. 2022 Aug 5;7(1):263. doi: 10.1038/s41392-022-01059-y. Signal Transduct Target Ther. 2022. PMID: 35927231 Free PMC article. Clinical Trial.

6

Characterization of Immune-Related Alternative Polyadenylation Events in Cancer Immunotherapy.

Wang G, Xie Z, Su J, Chen M, Du Y, Gao Q, Zhang G, Zhang H, Chen X, Liu H, Han L, Ye Y. Wang G, et al. Among authors: chen m, chen x. Cancer Res. 2022 Oct 4;82(19):3474-3485. doi: 10.1158/0008-5472.CAN-22-1417. Cancer Res. 2022. PMID: 35930727

7

CD147 mediates epidermal malignant transformation through the RSK2/AP-1 pathway.

Zhang X, Guo Y, Xiao T, Li J, Guo A, Lei L, Jin C, Long Q, Su J, Yin M, Liu H, Chen C, Zhou Z, Zhu S, Tao J, Hu S, Chen X, Peng C. Zhang X, et al. Among authors: chen c, chen x. J Exp Clin Cancer Res. 2022 Aug 13;41(1):246. doi: 10.1186/s13046-022-02427-w. J Exp Clin Cancer Res. 2022. PMID: 35964097 Free PMC article.

8

Sphingosine kinase 1 promotes tumor immune evasion by regulating the MTA3-PD-L1 axis.

Lau P, Zhang G, Zhao S, Liang L, Zhang H, Zhou G, Hung MC, Chen X, Liu H. Lau P, et al. Among authors: chen x. Cell Mol Immunol. 2022 Oct;19(10):1153-1167. doi: 10.1038/s41423-022-00911-z. Epub 2022 Sep 1. Cell Mol Immunol. 2022. PMID: 36050478 Free PMC article.

9

Multi-omics characterization of autophagy-related molecular features for therapeutic targeting of autophagy.

Luo M, Ye L, Chang R, Ye Y, Zhang Z, Liu C, Li S, Jing Y, Ruan H, Zhang G, He Y, Liu Y, Xue Y, Chen X, Guo AY, Liu H, Han L. Luo M, et al. Among authors: chen x. Nat Commun. 2022 Oct 26;13(1):6345. doi: 10.1038/s41467-022-33946-x. Nat Commun. 2022. PMID: 36289218 Free PMC article.

10

BET inhibitors synergize with sunitinib in melanoma through GDF15 suppression.

Zeng F, Li Y, Meng Y, Sun H, He Y, Yin M, Chen X, Deng G. Zeng F, et al. Among authors: chen x. Exp Mol Med. 2023 Feb;55(2):364-376. doi: 10.1038/s12276-023-00936-y. Epub 2023 Feb 1. Exp Mol Med. 2023. PMID: 36720918 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

107,951 results

Search Page